Therapeutic expertise

Infectious Disease Clinical Trial Sites

WCR evaluates infectious-disease and prevention-focused protocols through bilingual community access, trained research teams, sample-processing workflows, and coordinated study operations.

Program fit

Community-based research across two distinct markets

Feasibility considers epidemiology, target population, enrollment timing, testing, sample workflows, investigational product requirements, and participant follow-up.

  • Vaccine-preventable illness
  • Community infectious disease
  • Respiratory infection research
  • Prevention-focused programs
  • Protocol-specific treatment studies
  • Related healthy-volunteer research

Operational resources

  • Clinical sample processing
  • Cold and frozen storage
  • Sample packaging and shipment preparation
  • Bilingual community outreach
  • Miami and Puerto Rico placement options

For sponsors & CROs

Clinical assessment, specimen workflows and continued follow-up

WCR evaluates community-infection, respiratory-infection and prevention-focused protocols through its existing investigator network and coordinated clinical resources. The combined infectious-disease and vaccinology population informs feasibility without defining a protocol-eligible cohort. The influenza case provides a documented example of vaccine recruitment and participant follow-up, while laboratory, product-handling and clinical requirements remain study-specific.

From feasibility to study visits

  1. Review the infection or prevention indication, population and investigator fit.

  2. Coordinate specimen collection, processing, storage and shipment requirements.

  3. Plan communication and follow-up appropriate to the protocol and enrollment window.

Relevant investigator experience

Clinical experience behind the feasibility review

Miami Lakes, Florida

Lucky Flores, MD

Research experience across GI, dermatology, obesity, diabetes, respiratory disease, vaccines and women’s health.

Puerto Rico

Gustavo R. Albizu-Angulo, MD

Research experience in obesity, diabetes, cardiovascular risk, inflammatory bowel disease, vaccines, asthma and migraine.

Puerto Rico

Susane G. Santos Marrero, MD

Research experience in obesity, type 2 diabetes, cardiovascular risk, eosinophilic asthma and vaccines.

Investigator assignment, location suitability and study-specific resources are confirmed during feasibility. Explore both research locations

Related network experience

The work behind the study results

Phase 1/2

Influenza immunization

Early private-practice engagement and community outreach supported recruitment. Continued communication then carried those relationships through approximately a year of participation and follow-up.

Review this case study

For participants

Explore infectious-disease studies

The study team explains testing, visits, investigational treatments or vaccines, risks, and participant protections before enrollment.

View Enrolling Trials

Related expertise

Connected therapeutic areas

Evaluate an infectious-disease protocol